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Despite the well-known valuable role of necropsies in pa-
thology training and their indisputable importance for qual-
ity assurance in medical practice, the number of necropsies 
performed worldwide has decreased over the last few years. 
This has been ascribed, in part, to the idea that, at the time 
of death, most diagnoses have already been made using new 
diagnostic technologies, including clinical, morphological, 
and molecular pathology and imaging methods. In CLIN-
ICS 2008;63(5):581-8, Kotovicz et al.1 compared necropsy 
and clinical diagnosis at our large teaching hospital, where, 
although still performed, the number of necropsies has also 
declined. Unexpectedly, major missed diagnoses, which 
could have led to a change in management with increased 
survival or cure, were detected in 16.3% of cases. Minor 
diagnoses not directly related to the cause of death were 
detected in an additional 28.1% of cases. In a similar study 
at the Heart Institute of the same hospital, Saad et al.2 also 
found major disagreements regarding the cause of death 
in 30.0% of cases in a sequential series of 406 necropsies, 
mostly involving cardiovascular and respiratory diseases. In 
both articles, the authors quoted other studies from differ-
ent hospitals and countries, and found that, although new 
technological tools had indeed diminished the differences 
between clinical and necropsy findings, major diagnostic dis-
crepancies were found in 14 – 39% of cases, even in recent 
series from developed countries3-6. These papers highlight the 
occurrence of remarkable diagnostic failures, with important 
consequences for patient management.
One reason for the decline in autopsy rates seems to be 
family concern about the procedure. In the United Kingdom, 
this concern arose mainly after the revelation of unauthorized 
organ retention7. In Brazil, and possibly in other countries, 
there is a cultural desire that burials occur promptly, and 
families will not often consent to necropsies because of the 
delay caused by the procedure. Given this, pathology depart-
ments should try to decrease such delays as much as pos-
sible. However, at the Heart Institute, where for several years 
families were asked to consent to an autopsy upon hospital 
admission, the percent of family authorization (~60%) was 
much higher than the actual necropsy rate (~25%), indicating 
that, in many cases, even when consent is granted, physicians 
did not request a necropsy.
Thus, it seems reasonable to question what has caused 
this lack of physician interest. Some reasons might include: 
a desire to avoid ethical or legal problems that might arise 
if any kind of error or disagreement was found between 
the clinical and necropsy findings, procedural costs, or the 
perception that, with the presently available technology, 
there is little to be revealed by postmortem examination. 
Although this last idea is clearly contradicted by the articles 
of Kotovicz et al.,1 Saad et al.,2 and others quoted in those 
studies, it deserves further consideration. 
Necropsy results extend beyond individual cases. Even 
when one necropsy does not reveal any new findings, it may 
be performed as part of a study and thereby help identify 
morphological traits of diseases not readily apparent in indi-
vidual patients. This scenario is exemplified by the fact that 
most cases of cardiac amyloidosis are still diagnosed only at 
necropsy8. Furthermore, despite advances in image analysis 
and other methods, pulmonary embolism, endocarditis, and 
the initial phases of bronchopneumonia cannot currently be 
definitively diagnosed using imaging techniques alone7,8. 
Virtopsy9, which is a method of postmortem examination 
involving magnetic resonance imaging or tomography stud-
ies of a corpse, along with needle sampling, would probably 
also be of little help in many cases.
In a recent comment on the reasons behind the apparent 
diminution by physicians of the importance of necropsy, 
Pompilio and Vieira10 stated that this loss of interest might 
be related to the increasing influence of technological tools 
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in the practice of medicine. Indeed, the very concept of 
disease may be changing. In the past, nearly all conditions, 
except psychiatric disorders, were defined based on morpho-
logical pathology. Today, our understanding of disease and 
disease treatment is further enhanced by information related 
to genetic polymorphisms, cell counting, gene expression 
profiling, proteomics, and a type of “new-humoral” medi-
cine involving knowledge concerning cytokines and many 
other circulating molecules. Most of these new techniques 
should be major tools in the modern pathology laboratory, 
with each approach contributing to a more complete concept 
of disease. For example, a single disease might be linked to 
a number of different genetic polymorphisms affecting the 
production, destruction, or pre- or post-translational modi-
fication of a single protein. Similarly, the term “inflamma-
tory” infiltrate is no longer sufficient; the effect of such an 
infiltrate can depend on the subtype and functional status of 
each cell present, as some cell types modulate inflammation 
in a number of ways. 
On the other hand, imaging tools represent a large pro-
portion of newly available instruments. Their increasing 
importance reinforces the fact that morphologic pathology 
is still pivotal to diagnosis and to the definition of many dis-
eases. Except for situations in which movements or flows are 
required, all of these instruments attempt to examine, while 
the patient is still alive, alterations in human organs and cells 
that were previously detected only at necropsy. This suggests 
that necropsy remains the gold standard for diagnosis. For 
instance, the term “virtual histology” appears in 77 articles 
found via PubMed, 64 concerning intravascular ultrasound, 
10 on confocal laser endoscopy of the gastrointestinal tract, 
and 3 relating to other organs. As demonstrated in the article 
by Mauad et al.1, as well as others, significant differences 
still exist between virtual and real pathology. Therefore, 
in our opinion, teaching hospitals should strive to perform 
necropsies for 100% of in-hospital deaths. Only family 
denial should prevent the performance of these procedures, 
and efforts should be made to decrease the number of such 
cases. 
In conclusion, we believe that improved accuracy of 
new diagnostic methods could be achieved through closer 
collaboration between clinicians, radiologists, and clini-
cal and surgical pathologists. In many hospitals, including 
Hospital das Clínicas-FMUSP, such integration is rapidly 
growing within most sub-specialties (the most notable be-
ing fine-needle aspiration), yielding, in certain clinical con-
texts, major improvements in accuracy. Within this type of 
framework, necropsies will remain the gold standard for the 
multi-specialty approach to diagnosis and will guide us in 
the safe and optimal use of the present and future diagnostic 
armamentarium.
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